9FWI
Ensemble model of ligand-free SARS-CoV-2 NSP10-NSP14 (ExoN) and in complex with partially bound VT00025
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | MAX IV BEAMLINE BioMAX |
| Synchrotron site | MAX IV |
| Beamline | BioMAX |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2022-06-02 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.97625 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 43.980, 100.047, 51.242 |
| Unit cell angles | 90.00, 114.79, 90.00 |
Refinement procedure
| Resolution | 50.020 - 1.533 |
| R-factor | 0.1833 |
| Rwork | 0.182 |
| R-free | 0.19870 |
| Structure solution method | FOURIER SYNTHESIS |
| RMSD bond length | 0.011 |
| RMSD bond angle | 1.050 |
| Data reduction software | XDS (Jan 10, 2022) |
| Data scaling software | Aimless (0.7.7) |
| Phasing software | REFMAC |
| Refinement software | BUSTER (2.10.4) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 50.024 | 50.024 | 1.559 |
| High resolution limit [Å] | 1.533 | 4.160 | 1.533 |
| Rmerge | 0.054 | 0.039 | 0.808 |
| Rmeas | 0.059 | 0.042 | 0.874 |
| Rpim | 0.022 | 0.016 | 0.329 |
| Total number of observations | 417852 | 21185 | 20950 |
| Number of reflections | 60177 | 3067 | 3013 |
| <I/σ(I)> | 16.51 | 45.2 | 2.12 |
| Completeness [%] | 100.0 | 99.8 | 100 |
| Redundancy | 6.94 | 6.91 | 6.95 |
| CC(1/2) | 0.999 | 0.998 | 0.767 |
| Anomalous redundancy | 3.5 | 3.6 | 3.6 |
| CC(ano) | 0.144 | 0.181 | 0.013 |
| |DANO|/σ(DANO) | 0.8 | 1.2 | 0.7 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 293 | Morpheus buffer 2 (pH: 7.5): 0.10M - Morpheus Ethylene glycols: 36.50%w/v Morpheus Amino acids: 0.09M |






